Free Trial
NASDAQ:SPRB

Spruce Biosciences (SPRB) Stock Price, News & Analysis

Spruce Biosciences logo
$8.15 +0.67 (+8.96%)
As of 09/3/2025

About Spruce Biosciences Stock (NASDAQ:SPRB)

Key Stats

Today's Range
$7.36
$8.88
50-Day Range
$5.25
$11.39
52-Week Range
$0.06
$0.61
Volume
7,050 shs
Average Volume
802,052 shs
Market Capitalization
$4.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$131.25
Consensus Rating
Hold

Company Overview

Spruce Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
36th Percentile Overall Score

SPRB MarketRank™: 

Spruce Biosciences scored higher than 36% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Spruce Biosciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 6 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Spruce Biosciences has received no research coverage in the past 90 days.

  • Read more about Spruce Biosciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Spruce Biosciences are expected to grow in the coming year, from ($1.00) to ($0.85) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Spruce Biosciences is -8.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Spruce Biosciences is -8.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Spruce Biosciences has a P/B Ratio of 4.34. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Spruce Biosciences' valuation and earnings.
  • Percentage of Shares Shorted

    0.22% of the float of Spruce Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Spruce Biosciences has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Spruce Biosciences has recently increased by 96.45%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Spruce Biosciences does not currently pay a dividend.

  • Dividend Growth

    Spruce Biosciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.22% of the float of Spruce Biosciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Spruce Biosciences has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Spruce Biosciences has recently increased by 96.45%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    1 people have searched for SPRB on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Spruce Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.90% of the stock of Spruce Biosciences is held by insiders.

  • Percentage Held by Institutions

    91.71% of the stock of Spruce Biosciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Spruce Biosciences' insider trading history.
Receive SPRB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spruce Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SPRB Stock News Headlines

What's the Best Way to Lower RMD Taxes?
Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.tc pixel
Spruce Biosciences Announces Reverse Stock Split
SPRB Spruce Biosciences, Inc. - Seeking Alpha
See More Headlines

SPRB Stock Analysis - Frequently Asked Questions

Spruce Biosciences' stock was trading at $31.50 on January 1st, 2025. Since then, SPRB shares have decreased by 74.1% and is now trading at $8.15.

Spruce Biosciences, Inc. (NASDAQ:SPRB) announced its quarterly earnings data on Tuesday, April, 15th. The company reported ($42.75) EPS for the quarter, missing the consensus estimate of ($15.00) by $27.75. The firm earned $0.55 million during the quarter, compared to analysts' expectations of $0.50 million. Spruce Biosciences had a negative trailing twelve-month return on equity of 62.10% and a negative net margin of 555.23%.

Spruce Biosciences's stock reverse split before market open on Monday, August 4th 2025.The 1-75 reverse split was announced on Thursday, July 24th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 1st 2025. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Spruce Biosciences (SPRB) raised $75 million in an IPO on Friday, October 9th 2020. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Cowen, SVB Leerink, Credit Suisse and RBC Capital Markets acted as the underwriters for the IPO.

Shares of SPRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Spruce Biosciences investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), Adobe (ADBE), Meta Platforms (META) and Disc Medicine (IRON).

Company Calendar

Last Earnings
4/15/2025
Today
9/05/2025
Next Earnings (Estimated)
11/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SPRB
CIK
1683553
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$225.00
Low Price Target
$37.50
Potential Upside/Downside
+1,510.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($99.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$47.92 million
Net Margins
-555.23%
Pretax Margin
-555.23%
Return on Equity
-62.10%
Return on Assets
-47.49%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
5.36
Quick Ratio
5.36

Sales & Book Value

Annual Sales
$4.91 million
Price / Sales
0.93
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.88 per share
Price / Book
4.34

Miscellaneous

Outstanding Shares
562,000
Free Float
37,544,000
Market Cap
$4.58 million
Optionable
Optionable
Beta
2.43

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:SPRB) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners